J R Berger

Summary

Affiliation: University of Kentucky
Country: USA

Publications

  1. ncbi Paraneoplastic opsoclonus-myoclonus secondary to malignant melanoma
    J R Berger
    Department of Neurology, University of Kentucky College of Medicine, Lexington, USA
    J Neurooncol 41:43-5. 1999
  2. ncbi Cerebrovascular changes in the basal ganglia with HIV dementia
    J R Berger
    Department of Neurology, University of Kentucky College of Medicine, Lexington 40536 2184, USA
    Neurology 54:921-6. 2000
  3. ncbi JC virus detection in bodily fluids: clues to transmission
    Joseph R Berger
    Department of Neurology, College of Medicine, University of Kentucky, Lexington, KY 40536 0284, USA
    Clin Infect Dis 43:e9-12. 2006
  4. ncbi Familial lipodystrophy associated with neurodegeneration and congenital cataracts
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Lexington, USA
    Neurology 58:43-7. 2002
  5. ncbi Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Lexington, Kentucky 40536 0284, USA
    J Neurovirol 9:38-41. 2003
  6. ncbi Low prevalence of varicella zoster virus and herpes simplex virus type 2 in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy
    Chunmei C Wang
    Department of Oral Health Practice, University of Kentucky College of Medicine and College of Dentistry, Lexington, Kentucky 40536 0297, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109:232-7. 2010
  7. ncbi Acceleration of HIV dementia with methamphetamine and cocaine
    A Nath
    Department of Neurology, University of Kentucky, Lexington 40526-0284, USA
    J Neurovirol 7:66-71. 2001
  8. ncbi A brainstem paraneoplastic syndrome associated with prostate cancer
    J R Berger
    Department of Neurology, University of Kentucky College of Medicine, Kentucky Clinic L 445, 740 South Limestone Street, Lexington, KY 40536, USA
    J Neurol Neurosurg Psychiatry 80:934-5. 2009
  9. ncbi Acute multifocal placoid pigment epitheliopathy and central nervous system involvement: nine new cases and a review of the literature
    H S O'Halloran
    Department of Ophthalmology, University of Kentucky, Lexington, KY 40536, USA
    Ophthalmology 108:861-8. 2001
  10. ncbi Optic nerve edema as a consequence of respiratory disease
    H S O'Halloran
    Department of Ophthalmology, University of Kentucky, Lexington 40536, USA
    Neurology 53:2204-5. 1999

Collaborators

Detail Information

Publications65

  1. ncbi Paraneoplastic opsoclonus-myoclonus secondary to malignant melanoma
    J R Berger
    Department of Neurology, University of Kentucky College of Medicine, Lexington, USA
    J Neurooncol 41:43-5. 1999
    ..Antineuronal antibodies were not identified despite repeated testing. No therapeutic benefit was observed following corticosteroid administration...
  2. ncbi Cerebrovascular changes in the basal ganglia with HIV dementia
    J R Berger
    Department of Neurology, University of Kentucky College of Medicine, Lexington 40536 2184, USA
    Neurology 54:921-6. 2000
    ..Many investigators have proposed a contribution of a disrupted blood-brain barrier (BBB) to the pathogenesis of HIV dementia...
  3. ncbi JC virus detection in bodily fluids: clues to transmission
    Joseph R Berger
    Department of Neurology, College of Medicine, University of Kentucky, Lexington, KY 40536 0284, USA
    Clin Infect Dis 43:e9-12. 2006
    ....
  4. ncbi Familial lipodystrophy associated with neurodegeneration and congenital cataracts
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Lexington, USA
    Neurology 58:43-7. 2002
    ..The lipodystrophies are characterized by loss of body fat and metabolic disturbances, but the CNS is seldom affected...
  5. ncbi Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Lexington, Kentucky 40536 0284, USA
    J Neurovirol 9:38-41. 2003
    ..g., tat, and by inflammatory byproducts of HIV infection. It is quite likely that multiple diverse mechanisms are at play...
  6. ncbi Low prevalence of varicella zoster virus and herpes simplex virus type 2 in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy
    Chunmei C Wang
    Department of Oral Health Practice, University of Kentucky College of Medicine and College of Dentistry, Lexington, Kentucky 40536 0297, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109:232-7. 2010
    ..The aim of this study was to investigate the prevalence and amounts of VZV and HSV-2 in the saliva of HIV-infected orally asymptomatic patients...
  7. ncbi Acceleration of HIV dementia with methamphetamine and cocaine
    A Nath
    Department of Neurology, University of Kentucky, Lexington 40526-0284, USA
    J Neurovirol 7:66-71. 2001
    ..Careful attention and analysis to histories of remote non-injecting drug abuse may help substantiate our hypothesis...
  8. ncbi A brainstem paraneoplastic syndrome associated with prostate cancer
    J R Berger
    Department of Neurology, University of Kentucky College of Medicine, Kentucky Clinic L 445, 740 South Limestone Street, Lexington, KY 40536, USA
    J Neurol Neurosurg Psychiatry 80:934-5. 2009
    ..A rare paraneoplastic brainstem syndrome associated with prostate cancer is described, and the presence of antineuronal antibodies with this syndrome is demonstrated for the first time...
  9. ncbi Acute multifocal placoid pigment epitheliopathy and central nervous system involvement: nine new cases and a review of the literature
    H S O'Halloran
    Department of Ophthalmology, University of Kentucky, Lexington, KY 40536, USA
    Ophthalmology 108:861-8. 2001
    ..The study includes a review of the literature and discussion of evaluation, management, and treatment options...
  10. ncbi Optic nerve edema as a consequence of respiratory disease
    H S O'Halloran
    Department of Ophthalmology, University of Kentucky, Lexington 40536, USA
    Neurology 53:2204-5. 1999
    ..The opening pressure at the time of lumbar puncture was normal, and results of other CSF studies were normal. All abnormalities resolved with home oxygen therapy...
  11. ncbi Acute central cord syndrome with bodybuilder sign
    Patricio S Espinosa
    Department of Neurology, University of Kentucky College of Medicine, Kentucky Clinic Room L 445, Lexington, KY 40536 0284, United States
    Clin Neurol Neurosurg 109:354-6. 2007
    ....
  12. ncbi Alien hand syndrome
    Patricio S Espinosa
    Department of Neurology, Kentucky Clinic (Room L-445, Lexington, Kentucky 40536-0284, USA
    Neurology 67:E21. 2006
  13. ncbi Progressive multifocal leukoencephalopathy
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Kentucky Clinic L 445, 740 S Limestone Street, Lexington, KY 40536 0284, USA
    Curr Neurol Neurosci Rep 7:461-9. 2007
    ..Treatment directed against the JC virus has been unhelpful, but an increased understanding of disease pathogenesis may result in effective therapeutic strategies...
  14. ncbi Homonymous hemianopsia complicating treatment of postoperative epistaxis
    Patricio S Espinosa
    Department of Neurology, Kentucky Clinic, Lexington, KY 40536-0284, USA
    Neurology 67:1305. 2006
  15. ncbi High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy
    Craig S Miller
    Department of Microbiology, Immunology and Molecular Genetics, College of Medicine, University of Kentucky, 800 Rose Street, Lexington, KY 40536 0297, USA
    J Clin Microbiol 44:2409-15. 2006
    ..These findings suggest that saliva is a potential risk factor for the acquisition of multiple HHVs, and several host factors may function to accelerate HHV reactivation or replication in patients with HIV infection...
  16. ncbi Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Lexington, 40536, USA
    Neurol Res 28:299-305. 2006
    ..Studies in these populations will be invaluable in understanding the mechanisms of disease pathogenesis...
  17. ncbi Ziconotide infusion for severe chronic pain: case series of patients with neuropathic pain
    Daniel P Wermeling
    Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky Medical Center, Lexington, Kentucky 40536, USA
    Pharmacotherapy 26:395-402. 2006
    ..In all three cases, patients achieved considerable pain relief that was long-lasting and persisted well after dose administration or suspension of infusion...
  18. ncbi Primary lateral sclerosis with HIV-1 infection
    Ashok Verma
    Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA
    Neurology 70:575-7. 2008
  19. ncbi Neurological complications of herpes simplex virus type 2 infection
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Kentucky Clinic, Room L 445, 740 S Limestone St, Lexington, KY 40536 0284, USA
    Arch Neurol 65:596-600. 2008
    ..Despite a 50% genetic homology between HSV-1 and HSV-2, there are significant differences in the clinical manifestations of these 2 viruses. We herein review the neurological complications of HSV-2 infection...
  20. ncbi Neurologic consequences of autoimmune polyglandular syndrome type 1
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Kentucky Clinic L 445, 740 S Limestone Street, Lexington, KY 40536 0284, USA
    Neurology 70:2248-51. 2008
    ..The neurologic complications of this disorder have not been well characterized...
  21. ncbi Isolated central nervous system histoplasmosis in an immunocompetent patient: 53-month hiatus to diagnosis and treatment
    Joseph R Berger
    Departments of Neurology, University of Kentucky College of Medicine, Lexington, Kentucky 40536 0281, USA
    J Neurovirol 16:472-4. 2010
    ..We report a patient with chronic meningitis due to Histoplasma capsulatum who exhibited a remarkably benign course despite being untreated for the disorder for more than 4 years...
  22. ncbi Progressive multifocal leukoencephalopathy and newer biological agents
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Lexington, Kentucky 40536 0284, USA
    Drug Saf 33:969-83. 2010
    ..A biologically plausible explanation for the increased risk of PML will be proposed, as well as potential strategies for mitigating disease risk...
  23. ncbi A giant MS plaque mimicking PML during natalizumab treatment
    Cary Twyman
    Associates in Neurology, Lexington, KY 40536 0284, USA
    J Neurol Sci 291:110-3. 2010
    ..Distinguishing PML from MS may be very difficult in some instances. The frequency with which an aggressive demyelinating disorder due to MS occurs during treatment with natalizumab remains to be determined...
  24. ncbi Pearls: neurologic complications of HIV/AIDS
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Lexington, Kentucky, USA
    Semin Neurol 30:66-70. 2010
    ..Additionally, the complexity of evaluating the HIV-infected person with neurologic disease is increased by the relatively high frequency with which more than one disease concurrently affects the nervous system...
  25. ncbi Monoclonal antibodies and progressive multifocal leukoencephalopathy
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Lexington, Kentucky, USA
    MAbs 1:583-9. 2009
    ..Based on our current understanding of the biology of JC virus and the pathogenesis of PML, we propose an explanation for the increased risk for PML that is observed with natalizumab and certain other monoclonal antibodies...
  26. ncbi Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study
    Aaron Boster
    Department of Neurology, Wayne State University School of Medicine, Detroit, MI 48201, USA
    Arch Neurol 66:593-9. 2009
    ..To identify clinical and magnetic resonance imaging (MRI) features that distinguish progressive multifocal leukoencephalopathy (PML) from relapsing-remitting multiple sclerosis (RRMS)...
  27. ncbi Opportunistic infections and other risks with newer multiple sclerosis therapies
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Lexington, KY, USA
    Ann Neurol 65:367-77. 2009
    ..Determining the actual risk frequency for many of these complications will likely require careful postmarketing surveillance...
  28. ncbi Cystinosis of the brain and spinal cord with associated vasculopathy
    Joseph R Berger
    Department of Neurology, The University of Kentucky College of Medicine, Lexington, Kentucky 40536 0284, USA
    J Neurol Sci 284:182-5. 2009
    ..As more patients with cystinosis experience long term survival, there will likely be an increased frequency of CNS disease...
  29. ncbi Cerebrospinal fluid proteomics and human immunodeficiency virus dementia: preliminary observations
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Lexington, Kentucky 40536 0284, USA
    J Neurovirol 11:557-62. 2005
    ..In both serum and CSF samples, differences in protein intensity appeared to correlate with degree of dementia. This preliminary study suggests that protein markers of HIV dementia may be detected by MALDI mass spectrometry...
  30. ncbi Natalizumab
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Kentucky Clinic, Lexington, Kentucky 40536 0284, USA
    Drugs Today (Barc) 42:639-55. 2006
    ..Postmarketing surveillance studies should answer this and other questions related to the use of natalizumab...
  31. ncbi AIDS and stroke risk
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Lexington, Kentucky, USA
    Lancet Neurol 3:206-7. 2004
  32. ncbi Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance?
    Malcolm J Avison
    Dept of Neurology, University of Kentucky College of Medicine, Lexington, KY 40536 2184, USA
    Trends Neurosci 25:468-73. 2002
    ..This could perhaps explain the variability in HIVD development, progression and response to therapy. These findings also suggest that MRI and MRS can identify patients at risk for HIVD and predict response to therapy...
  33. ncbi Volitional opsoclonus
    Patricio S Espinosa
    Department of Neurology, Kentucky Clinic, Lexington, Kentucky 40536-0284, USA
    Neurology 65:E11. 2005
  34. ncbi Coxsackie B meningoencephalitis in a patient with acquired immunodeficiency syndrome and a multiple sclerosis-like illness
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Lexington, Kentucky 40536, USA
    J Neurovirol 15:282-7. 2009
    ..This is the first case report, to the best of our knowledge, of an enteroviral meningoencephalitis complicating human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS)...
  35. ncbi Brachial amyotrophic diplegia in a patient with human immunodeficiency virus infection: widening the spectrum of motor neuron diseases occurring with the human immunodeficiency virus
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Lexington, KY 40536 0284, USA
    Arch Neurol 62:817-23. 2005
    ..This disorder may represent one end of a spectrum of motor neuron diseases occurring with this retrovirus infection...
  36. ncbi Intravascular lymphomatosis presenting with sudden hearing loss
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Lexington, KY 40536 0284, USA
    J Neurol Sci 232:105-9. 2005
    ..We report a patient in whom sudden hearing loss heralded IVL and propose that the hearing loss may have been the consequence of labyrinthine infarction consequent to the aggregation of malignant cells in the internal auditory artery...
  37. ncbi The blood brain barrier in HIV infection
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Kentucky Clinic L 445, Lexington, KY 40536 0284, USA
    Front Biosci 9:2680-5. 2004
    ..Additionally, BBB disruption has implications with respect to antiretroviral therapy. This review will address these issues...
  38. ncbi Neuroimaging correlates of HIV-associated BBB compromise
    Malcolm J Avison
    Department of Neurology, University of Kentucky Medical Center, Lexington, KY, USA
    J Neuroimmunol 157:140-6. 2004
    ..Additionally, they suggest a salutary effect of HAART on the incidence and severity of HAD, which may, in part, be due to protection of BBB integrity...
  39. ncbi Infectious myelopathies
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Lexington 40536, USA
    Semin Neurol 22:133-42. 2002
    ..This review addresses the infectious myelopathies by microorganism...
  40. ncbi Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia
    Malcolm J Avison
    Department of Neurology, University of Kentucky Medical Center, Lexington, USA
    J Neurovirol 10:223-32. 2004
    ..These results suggest that early CNS inflammation may underlie the microvascular changes observed, and may be a factor in the development of HIV dementia...
  41. ncbi Paradoxically aggressive multiple sclerosis in the face of natalizumab therapy
    J R Berger
    Department of Neurology, University of Kentucky College of Medicine, 740 S Limestone Street, Lexington, KY 40536, USA
    Mult Scler 14:708-10. 2008
    ..Neutralizing antibodies to natalizumab were not detected. She subsequently responded to combination therapy of pulsed methylprednisolone and daily glatiramer acetate...
  42. ncbi Molecular targets of opiate drug abuse in neuroAIDS
    K F Hauser
    Department of Anatomy and Neurobiology, University of Kentucky Medical Center, Lexington, KY 40536, USA
    Neurotox Res 8:63-80. 2005
    ....
  43. ncbi ALS syndrome in patients with HIV-1 infection
    Ashok Verma
    Department of Neurology, Kessenich Family MDA ALS Center, University of Miami Miller School of Medicine, 1150 NW 14 Street, Suite 701, Miami, FL 33136, USA
    J Neurol Sci 240:59-64. 2006
    ..During the last 20 years, at least 19 cases of ALS or ALS-like disease have been reported in HIV-1 (HIV) seropositive individuals...
  44. ncbi Monofocal acute inflammatory Demyelination (MAID): a unique disorder simulating brain neoplasm
    José A Gutrecht
    Department of Neurology, Lahey Clinic Medical Center, Burlington, Mass, USA
    South Med J 95:1180-6. 2002
    ..Monofocal acute inflammatory demyelinating (MAID) lesions present as large masses that mimic brain tumors. The natural history and nosologic classification are not well defined...
  45. ncbi HIV and the central nervous system
    Meriem K Bensalem
    Department of Neurology, University of Kentucky College of Medicine, Kentucky Clinic, L-445, Lexington, KY 40536-0284, USA
    Compr Ther 28:23-33. 2002
    ..The spectrum of neurological disease is broad. This article highlights the common disorders of the central nervous system associated with HIV/AIDS...
  46. ncbi Persistent Coxsackie B encephalitis: Report of a case and review of the literature
    Joseph R Berger
    Department of Neurology, Internal Medicine, University of Kentucky College of Medicine, Lexington, Kentucky 40536-0284, USA
    J Neurovirol 12:511-6. 2006
    ..It also emphasizes the importance of performing brain biopsy on individuals with neurological disease of obscure nature...
  47. ncbi Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants
    J Turchan
    Department of Neurology, Pharmaceutical Sciences, University of Kentucky, Lexington, USA
    Neurology 60:307-14. 2003
    ..The authors have identified several novel compounds that are capable of blocking the CSF-induced toxicity, the therapeutic potential of which is worthy of further exploration...
  48. ncbi Natalizumab and progressive multifocal leucoencephalopathy
    J R Berger
    Department of Neurology, University of Kentucky College of Medicine, Kentucky Clinic L 445, 740 S Limestone Street, Lexington, KY 40536 0284, USA
    Ann Rheum Dis 65:iii48-53. 2006
    ..It is likely that use of drugs which cause specific perturbations of the immune system will be accompanied by similar rare infections. Thus researchers should be on the alert when using such agents in clinical trials...
  49. ncbi The HIV Dementia Scale: predictive power in mild dementia and HAART
    Kara Anne Bottiggi
    Graduate Center for Gerontology, College of Public Health, University of Kentucky, KY, USA
    J Neurol Sci 260:11-5. 2007
    ..With the advent of highly active antiretroviral therapy (HAART), the use of sensitive and efficient screening tests for HIV-D continue to be needed for identifying individuals who develop this disorder...
  50. ncbi Stroke in HIV infection and AIDS
    Michael R Dobbs
    Department of Neurology, University of Kentucky College of Medicine, Lexington, KY, USA
    Expert Rev Cardiovasc Ther 7:1263-71. 2009
    ..Selecting the appropriate therapy for treating stroke in the HIV-infected patient is dependent on diagnostic rigor in identifying its underlying etiology...
  51. ncbi The neurological complications of bariatric surgery
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Lexington 40536-0284, USA
    Arch Neurol 61:1185-9. 2004
  52. ncbi Cervical myelopathy secondary to violent tics of Tourette's syndrome
    Michael Dobbs
    Department of Neurology, University of Kentucky College of Medicine, Lexington, KY 40536-0284, USA
    Neurology 60:1862-3. 2003
  53. ncbi Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy
    Marco A Lima
    Department of Neurology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215, USA
    J Virol 81:3361-8. 2007
    ..Immunotherapies aiming at increasing the cellular immune response against JCV may be valuable in the treatment of HIV+ individuals with PML...
  54. ncbi Hereditary hemorrhagic telangectasia and spinal cord infarct: case report with a review of the neurological complications of HHT
    Patricio S Espinosa
    Department of Neurology, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
    Clin Neurol Neurosurg 110:484-91. 2008
    ..While myelopathy secondary to arteriovenous malformation with HHT has been previously reported, this is the first instance of spinal cord infarction due to paradoxical embolization in this disorder...
  55. ncbi The "bedsheet" Babinski
    Joseph R Berger
    Department of Neurology, University of Kentucky College of Medicine, Kentucky Clinic, Lexington 40536-0284, USA
    South Med J 95:1178-9. 2002
    ....
  56. ncbi JCV-specific CD4 T cell response: another piece of the puzzle in explaining some aspects of AIDS associated PML
    Joseph R Berger
    AIDS 17:1557-9. 2003
  57. ncbi Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences
    Joseph R Berger
    N Engl J Med 353:414-6. 2005
  58. ncbi A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy
    Giovanni Schifitto
    University of Rochester, Rochester, New York 14620, USA
    J Neurovirol 12:328-31. 2006
    ..Results were similar to those of other pilot studies of memantine for neuropathic pain unrelated to HIV, suggesting that memantine is ineffective for the symptomatic treatment of HIV-associated SDSP...
  59. ncbi Reply to "'Thinking without thinking' about natalizumab and PML"
    Sidney Houff
    J Neurol Sci 264:198-9; author reply 199. 2008
  60. ncbi Parinaud syndrome heralding MS
    William B Lee
    University of California, Davis Medical Center, 4860 Y Street, Suite 2400, Sacramento, CA 95817, USA
    Neurology 60:322. 2003
  61. ncbi Identification of potential antibody markers in HIV-associated dementia
    Steven E Schutzer
    Department of Medicine, UMDNJ New Jersey Medical School, 185 South Orange Ave, Newark, NJ 07103, USA
    J Neuroimmunol 157:120-5. 2004
    ..All 11 non-HIV-1 controls were negative. These and published data suggest antibrain antibodies and IC may serve as markers of HAD...
  62. ncbi Proceedings of the 10th International Conference on Neuroscience of HIV Infection: emerging issues
    Hans Jürgen von Giesen
    Neurologische Klinik der Heinrich Heine Universität Düsseldorf, Dusseldorf, Germany
    J Neurovirol 8:3-7. 2002
    ..Viral opportunistic infections (e.g., JCV infection resulting in progressive multifocal leukoencephalopathy) as well as coinfection with hepatitis C represented a further topic...
  63. ncbi Mass lesions of the brain in AIDS: the dilemmas of distinguishing toxoplasmosis from primary CNS lymphoma
    Joseph R Berger
    AJNR Am J Neuroradiol 24:554-5. 2003
  64. ncbi Autoimmune markers in HIV-associated dementia
    Steven E Schutzer
    Department of Medicine, UMDNJ New Jersey Medical School, 185 South Orange Avenue, Newark, NJ 07103, USA
    J Neuroimmunol 138:156-61. 2003
    ..Reactivity against control tissue was negative. Though the etiopathogenetic relation of these antibrain antibodies remains to be delineated, the data suggest that they may be a marker of HAD...
  65. ncbi An international screening tool for HIV dementia
    Joseph R Berger
    AIDS 19:2165-6. 2005